Posted in Clinical Data Amgen scores with new thyroid eye disease formulation April 7, 2026 Pharmaphorum Can Amgen’s subcutaneous version of Tepezza inject renewed growth into the thyroid eye disease blockbuster? Clinical DataOphthalmologyRead full story